Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01646827 · ClinicalTrials.gov registry record · Phase 1
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
A Phase 1 study, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT01646827 is a Phase 1 study that has completed, run by Otsuka Pharmaceutical Development & Commercialization. The registered enrollment target is 37 participants.
The verdict
NCT01646827, a Phase 1 study, has completed, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether aripiprazole injection into the shoulder or the buttocks produces similar effects in the body
Interventions
- DRUG Aripiprazole IM Depot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01646827
The ClinicalTrials.gov registry entry for NCT01646827 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otsuka Pharmaceutical Development & Commercialization, which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole IM Depot is the first listed.
NCT01646827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01646827 about?
NCT01646827 is a clinical study titled "An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia". The purpose of this study is to determine whether aripiprazole injection into the shoulder or the buttocks produces similar effects in the body
What is the current status of trial NCT01646827?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2012-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01646827?
The interventions under investigation include: Aripiprazole IM Depot (DRUG).
Who is sponsoring clinical trial NCT01646827?
This trial is sponsored by Otsuka Pharmaceutical Development & Commercialization, which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.